Bioscience

EMEA, FDA jointly qualify renal biomarkers

June 6, 2008

By Flinn Foundation

[Source: EMEA] – The European Medicines Agency (EMEA) and the US Food and Drug Administration (FDA) have concluded their first joint qualification process for biomarkers.

Based on pooled data submitted by the Critical Path Institute